Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Shire Rises As US FDA Approves Takhzyro Drug

Fri, 24th Aug 2018 10:39

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------Shire, up 2.6%. The Irish pharmaceutical company said the US Food & Drug Administration has approved its Takhzyro drug to treat a rare genetic disease. The disease, hereditary angioedema, causes attacks of swelling in different parts of the body and can be life-threatening. Approval from the FDA follows a phase III study of 125 patients in which Takhzyro reduced monthly attacks by, on average, 87% in patients when compared with a placebo. Antofagasta, up 2.0%. RBC Capital upgraded the Chilean copper miner to Outperform from Sector Perform. ----------FTSE 100 - LOSERS----------Berkeley Group, down 2.3%, Barratt Developments, down 1.9%, Persimmon, down 1.7%, Taylor Wimpey, down 1.2%. The housebuilders were lower amid a decline in UK mortgage approvals in July. The number of mortgages approved in July fell to 39,584 from 40,330 in June. Economists had forecast approvals to rise to 40,650, data from UK Finance showed. "Housebuilders have taken a knock as a double whammy of lower new approved mortgages and a five-month low in mortgage lending weighed on the sector," IG Group analyst Chris Beauchamp said. Midcap peers McCarthy & Stone, Bovis Homes and Bellway were down 2.1%, 1.4% and 1.2%, respectively. ----------FTSE 250 - WINNERS----------Ted Baker, up 2.0%. Peel Hunt raised the high street fashion retailer to Add from Hold. ----------OTHER MAIN MARKET AND AIM - WINNERS----------Henry Boot, up 4.5%. The construction company said interim profit and revenue both rose in an "impressive" first half performance. For the six months to June, Henry Boot's pretax profit was up 16% to GBP26.2 million, while revenue rose slightly to GBP196.2 million from GBP195.4 million a year prior. Its net asset value per share increased by 18% to 217 pence. Henry Boot is paying an interim dividend to shareholders of 3.20p, from 2.80p a year prior. The company said it has seen "consistent" levels of demand across all of its businesses in the first half of 2018, particularly in housing development land. ----------OTHER MAIN MARKET AND AIM - LOSERS----------Bahamas Petroleum, down 63%. The oil and gas explorer said its exclusivity agreement with a major international oil company will terminate at the end of the month. The unnamed international company has notified Bahamas that it will not be extending the agreement, which has been in place since the start of May, past next Friday and will cease exclusivity payments. Bahamas said it has recommenced broader asset-based discussions with third parties. These will continue alongside the ongoing non asset-based discussions which surround the funding of its first exploration well.----------
More News
26 Apr 2018 12:14

Bid target Shire reports 6 pct rise in first-quarter earnings

LONDON, April 26 (Reuters) - Shire, the London-listed drugmaker targeted by Takeda Pharmaceutical, reported a 6 percent rise in first-quarter earnings on Thursday, helped by higher product sales a

Read more
26 Apr 2018 07:32

Doubts Over Shire's Credit Profile If Bought By Takeda - Moody's

LONDON (Alliance News) - Moody's Investors Service late Wednesday expressed uncertainty regarding biotechnology company Shire PLC's credit profile following a potential acquisition by Co -

Read more
26 Apr 2018 06:56

LONDON MARKET EARLY CALL: Shell, Barclays Earnings Due; ECB In Focus

LONDON (Alliance News) - Stocks in London are set to open marginally higher on Thursday, supported by some gains in the US overnight, with focus for the day ahead on the European Central latest at

Read more
26 Apr 2018 06:42

UPDATE 1-Roche lifts 2018 outlook as Ocrevus shines, Tecentriq stumbles

ZURICH, April 26 (Reuters) - Roche raised its 2018 sales outlook on Thursday after getting a lift in the first three months of the year from newer drugs including multiple sclerosis medicine the 6

Read more
25 Apr 2018 17:07

European Markets Drop With Interest Rate Hike Concerns

BRUSSELS/FRANKFURT/PARIS (Alliance News) - The European markets ended Wednesday's session firmly in negative territory. Investor sentiment took a hit after Wall Street stocks sold off Tuesday

Read more
25 Apr 2018 16:02

Reuters Business News Schedule at 1500 GMT/11 AM ET

Editor: Steve Orlofsky +1 646 223 6200 Global Picture Desk: +65 6870 3775 Global Graphics Desk: + 65 6870 3595 (All times GMT / ET) Receive this schedule by confirms -

Read more
25 Apr 2018 13:30

Reuters Business News Schedule at 1230 GMT/8:30 AM ET

Editor: Louise Heavens, +44 207 542 1897 Global Picture Desk: +65 6870 3775 Global Graphics Desk: + 65 6870 3595 (All times GMT / ET) Receive this schedule by pulls for

Read more
25 Apr 2018 12:39

GSK rules out entering Shire takeover battle

LONDON, April 25 (Reuters) - GlaxoSmithKline's chief executive said on Wednesday she had no interest in acquiring Shire, the London-listed rare diseases specialist that Takeda Pharmaceutical

Read more
25 Apr 2018 10:36

ANALYSIS-Shire bid marks Takeda's latest - and biggest - push for global status

* CEO Weber continuing predecessor's international push * Japan already accounts for only 30 percent of Takeda's drug sales * Takeda is trying to rebuild its $64 bln Shire 25

Read more
25 Apr 2018 09:03

FOREX-Firm yields push dollar to a 4-month high

* Dollar rises 0.3 percent on U.S. yields * Investors focused on Thursday's ECB meeting * Graphic: World FX rates in 2018 http://tmsnrt.rs/2egbfVh By Tom April 25 - The a

Read more
25 Apr 2018 07:02

TOP NEWS: Shire Board To Recommend Revised GBP46 Billion Takeda Offer

LONDON (Alliance News) - Shire PLC said late Tuesday that its board is willing to recommend a revised merger proposal worth GBP46 billion made by Japanese pharmaceutical company Takeda Co Ltd to a

Read more
25 Apr 2018 06:59

LONDON MARKET EARLY CALL: Lower Call; Shire And Takeda Reach Deal

LONDON (Alliance News) - Stock prices in London are set to open lower on Wednesday after equities in the US slumped on Tuesday.This comes amid a quiet day for economic data ahead of the on

Read more
25 Apr 2018 04:19

FOREX-Dollar edges up as US yields poke above 3 percent to 4-year highs

* Dollar index edges up towards 4-month highs * 10-yr US yield pokes above 3 pct for first time since early 2014 * Widening yield spreads seen supporting dollar long term * at

Read more
24 Apr 2018 19:40

Reuters Business News Schedule at 1830 GMT/2:30 PM ET

Editor: Steve Orlofsky +1 646 223 6200 Global Picture Desk: +65 6870 3775 Global Graphics Desk: + 65 6870 3595 (All times GMT / ET) Receive this schedule by St sunk by

Read more
24 Apr 2018 17:17

European Markets Finished Mixed After Early Gains Erode

BRUSSELS/FRANKFURT/PARIS (Alliance News) - The European markets ended Tuesday's session with mixed results. After a positive start to the day, the market began to pare their early gains in the

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.